---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-21-332489"
form_type: "8-K"
ticker: "BVS"
cik: "0001665988"
company_name: "Bioventus Inc."
filed_at: "2021-11-17T23:59:59+00:00"
generated_at: "2026-06-28T07:24:38.187230+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Bioventus CFO Greg Anglum to depart; search for successor underway

## Summary
- CFO Greg Anglum is leaving Bioventus to pursue other career opportunities.
- Anglum will remain in his role until a successor is appointed.
- No interim CFO or specific timeline for replacement has been announced.

## SEC filing metadata
- accession: 0001193125-21-332489
- form_type: 8-K
- ticker: BVS
- cik: 0001665988
- company_name: Bioventus Inc.
- filed_at: 2021-11-17T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1665988/000119312521332489/0001193125-21-332489-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1665988/000119312521332489/d267305d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-21-332489
- JSON: https://secwatch.observer/filing/0001193125-21-332489.json
- Plain text: https://secwatch.observer/filing/0001193125-21-332489.txt

## Key facts
- Executive change
  Greg Anglum changed role as Senior Vice President and Chief Financial Officer at Bioventus Inc..
  - Action: transition from his role
  - Role: Senior Vice President and Chief Financial Officer
  source text: On November 11, 2021, Bioventus Inc. (the “Company”) determined that Greg Anglum, the Company’s Senior Vice President and Chief Financial Officer and principal accounting officer, would transition from his role to pursue other career opportunities.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1665988/000119312521332489/0001193125-21-332489-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.